Harbour BioMed

Beijing International Trade CBD Building Complex China
Biotech

AstraZeneca details $2.5B investment in China's political center

AstraZeneca has shown its commitment to China amid investigations into its activities, outlining plans to establish a global R&D center in Beijing.
Nick Paul Taylor Mar 21, 2025 8:35am
boat cutting through water

Harbour launches obesity biotech on mission to preserve muscle

Mar 12, 2025 8:15am
Three blocks displaying from left to right a person a handshake and another person

Harbour spinoff pens $395M deal for preclinical Crenessity rival

Feb 26, 2025 5:14am
windmill turbines in the Netherlands

Windward generates $200M with Novo Holdings, OrbiMed in tow

Jan 10, 2025 10:02am
Deal terminate tear up end deal scrap

Cullinan, after $25M deal, hands back bispecific to Harbour

Aug 8, 2024 10:10am
mice model mouse running

AstraZeneca pays $19M for Nona's preclinical cancer antibodies

May 23, 2024 5:58am